Prevnar 13 Dosage
Links shared publicly online about this topic.
- 835total visits
Prevnar 13 Dosage
View full resource at kids.emedtv.com
Tags: Vaccination, Pneumococcal Vaccine, Vaccine, Prevnar
Most Recently Shared on October 1, 2010 at 1:09 am By:
Just added http://bit.ly/9oguIw to the Prevnar 13 Dosage WisdomCard http://bit.ly/94soZd @organizedwisdom
Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints
news-medical.net — “Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.” View full resource at news-medical.net
Most Recently Shared on March 12, 2012 at 4:16 pm By:
Meningitis News: Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints: Pfizer In... http://t.co/PztJUU3n
Phase 3 Study Update of Prevnar 13 for Pneumococcal Vaccination in Older Children and Adolescents - MPR
empr.com — “Pfizer announced that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5-17 years.” View full resource at empr.com
Most Recently Shared on March 12, 2012 at 2:26 pm By:
Phase 3 Study Update of #Prevnar 13 for Pneumococcal #Vaccination in Older Children and Adolescents http://t.co/lK3eB0L1 #immunization
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's - Yahoo! Finance UK
uk.finance.yahoo.com — “Read 'UPDATE 1-Pfizer says its drug is best hope for Alzheimer's' on Yahoo! Finance UK. * Says prior trials suggest edge over Lilly Alzheimer's drug * Says Prevnar 13 pneumonia data expected by 2013 * Expects FDA panel to review arthritis drug (Adds quotes from research chief, details on ...” View full resource at uk.finance.yahoo.com
Most Recently Shared on February 14, 2012 at 7:37 pm By:
UPDATE 1-Pfizer says its drug is best hope for Alzheimer's: * Says prior trials suggest edge over Lilly Alzheime... http://t.co/I53zjiUn
News in Brief: Week of Jan. 2-6 -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “This roundup includes the following news briefs: Similarity in Drug Names Poses Serious Injury Risk, Says FDA; FDA Votes to Expand Prevnar 13 Indication; PCMHs, Physician-led Networks Generate Savings for N.C. Medicaid Program; HHS Awards Bonuses for State Medicaid, CHIP Program Expansions; and CHFM Seeks Fellowship Applicants.” View full resource at aafp.org
Most Recently Shared on January 6, 2012 at 1:36 am By:
News in Brief: Week of Jan. 2-6 http://t.co/9a7vkaXB
Pneumonia Vaccine Approved by FDA Called Prevnar 13 from Pfizer | Z6Mag
z6mag.com — “Pneumonia Vaccine Approved by FDA Called Prevnar 13 from Pfizer | Z6Mag” View full resource at z6mag.com
Most Recently Shared on January 4, 2012 at 10:04 pm By:
Healthcare In Focus Health Site
FDA approves new pneumonia vaccine, developed by Pfizer, for adults 50 and over http://t.co/mcMBlbBN @pfizer_news
FDA Greenlights Pneumonia Vaccine
medicalnewstoday.com — “The FDA has approved Prevnar 13, for use on people over 50. Prevnar 13 is a pneumococcal 13-valent conjugate vaccine, that can prevent pneumonia and disease caused by the bacterium, Streptococ” View full resource at medicalnewstoday.com
Most Recently Shared on January 2, 2012 at 6:05 pm By:
MedicalNewsToday: FDA Greenlights Pneumonia Vaccine http://t.co/CVwo11L4 Full http://t.co/XexlS93r
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults
news-medical.net — “Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the Company's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults.” View full resource at news-medical.net
Most Recently Shared on December 31, 2011 at 9:55 am By:
Meningitis News: FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults: Pf... http://t.co/4eorFS2i
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)
theannals.com — “Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December)” View full resource at theannals.com
Most Recently Shared on November 2, 2011 at 3:45 am By:
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine (December): OBJECTIVE:To review the immunogenicity,... http://t.co/UCOTnIgs
Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA
news-medical.net — “Pfizer Inc. announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) conducted in adults 50 years and older will be presented during the 49th Annual Meeting of the Infectious Diseases Society of America, which is being held Oct. 20-23, 2011, in Boston, Mass.” View full resource at news-medical.net
Most Recently Shared on October 22, 2011 at 5:24 pm By:
Meningitis News: Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA: Pfizer... http://t.co/bq603Ytp
Additional Data From Pfizer's Prevnar 13 Clinical Trials In Adults 50 Years And Older To Be Presented At The 49th Annual Meeting Of The Infectious Diseases Society Of America - Drugs.com MedNews
drugs.com — “Oct 21, 2011 - Pfizer Inc. (NYSE PFE) announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine” View full resource at drugs.com
Most Recently Shared on October 21, 2011 at 3:15 pm By:
Drugs and Devices OW OW Health
Additional Data From Pfizer's Prevnar 13 Clinical Trials In Adults 50 Years And Older To Be Presented At T... http://t.co/IqxTuLlB #drug
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults
news-medical.net — “Pfizer Inc today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sBLA) for use of Prevnar 13, in adults aged 50 and older.” View full resource at news-medical.net
Most Recently Shared on July 30, 2011 at 1:59 pm By:
Meningitis News: FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults: Pfizer I... http://bit.ly/ojN4b7
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults
news-medical.net — “Pfizer Inc today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sBLA) for use of Prevnar 13, in adults aged 50 and older.” View full resource at news-medical.net
Most Recently Shared on July 30, 2011 at 7:43 am By:
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults: Pfizer Inc today announce... http://bit.ly/qx8Dmp
Pfizer Provides U.S. Regulatory Update on Prevnar 13? for Use in Adults 50 Years and Older 29.07.2011 | Nachricht | finanzen.net
finanzen.net — “Pfizer Provides U.S. Regulatory Update on Prevnar 13? for Use in Adults 50 Years and Older 29.07.2011 | Nachricht | finanzen.net” View full resource at finanzen.net
Most Recently Shared on July 29, 2011 at 7:40 pm By:
Pfizer Provides U.S. Regulatory Update on Prevnar 13® for Use in Adults 50 Years and Older: Pfizer Inc (NYSE:PFE... http://bit.ly/qUoV1J
The Day - Is Prevnar 13 Pfizer’s next big thing? | News from southeastern Connecticut
theday.com — “The Day - Is Prevnar 13 Pfizer’s next big thing? | News from southeastern Connecticut” View full resource at theday.com
Most Recently Shared on May 10, 2011 at 11:48 am By:
Is Prevnar 13 Pfizer's next big thing? http://bit.ly/mh3x71
Prevnar 13 Vaccine For Pneumococcal Disease For Adults Meets All Endpoints
medicalnewstoday.com — “Prevnar 13, a pneumonia vaccine, was found effective for patients aged 50+ in two clinical trials as its maker, Pfizer, applies to expand the vaccine's use. Pfizer says the vaccine met all study e” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2011 at 7:05 am By:
Prevnar 13 Vaccine For Pneumococcal Disease For Adults Meets All Endpoints http://mnt.to/3VBH #healthnews
Advertisement
